BridgeBio Pharma: Set For New Commercial Launches After Trial Successes
Source: SeekingAlpha
2025-11-23 07:04:57 ET
Introduction
BridgeBio (BBIO) has risen roughly 90% since I initiated coverage back in April of 2025. It quickly became the largest position in my portfolio and was the primary driver of my outperformance this year....
Read the full article on Seeking Alpha
For further details see:
BridgeBio Pharma: Set For New Commercial Launches After Trial Successes
BridgeBio Pharma Inc.
NASDAQ: BBIO
BBIO Trading
4.56% G/L:
$71.475 Last:
418,087 Volume:
$69.29 Open:
BBIO Latest News
BBIO Stock Data
$13,905,867,946
157,635,809
2.34%
155
N/A
Biotechnology & Life Sciences
Healthcare
US
Palo Alto
